Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Amrutanjan Health Care Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹481.30Overvalued by 14.36%vs CMP ₹562.00

P/E (25.2) × ROE (18.5%) × BV (₹128.00) × DY (0.82%)

₹247.62Overvalued by 55.94%vs CMP ₹562.00
MoS: -127% (Negative)Confidence: 68/100 (Moderate)Models: All 9: Overvalued
ModelCategoryValueWeightSignal
PE-ROEEarnings₹466.5722%Over (-17%)
Graham NumberEarnings₹238.0716%Over (-57.6%)
Earnings PowerEarnings₹129.4013%Over (-77%)
DCFCash Flow₹201.9113%Over (-64.1%)
Net Asset ValueAssets₹127.887%Over (-77.2%)
EV/EBITDAEnterprise₹179.049%Over (-68.1%)
Earnings YieldEarnings₹196.807%Over (-65%)
ROCE CapitalReturns₹223.199%Over (-60.3%)
Revenue MultipleRevenue₹156.235%Over (-72.2%)
Consensus (9 models)₹247.62100%Overvalued

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -3.1%

*Investments are subject to market risks

Analyst Summary

Amrutanjan Health Care Ltd operates in the Pharmaceuticals segment, NSE: AMRUTANJAN | BSE: 590006, current market price is ₹562.00, market cap is 1,626 Cr.. At a glance, stock P/E is 25.2, ROE is 18.5 %, ROCE is 24.8 %, book value is 128, dividend yield is 0.82 %. The latest intrinsic value estimate is ₹247.62, around 55.9% below the current price, so expectations may already be running ahead of this modelled fair value. On operating trend, latest reported sales are about ₹452 Cr versus the prior period change of 7.4%, while latest net profit is about ₹51 Cr with a prior-period change of 13.3%. The 52-week range shown on this page is 791/486, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisAmrutanjan Health Care Ltd. is a Public Limited Listed company incorporated on 09/09/1936 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN…

This summary is generated from the stock page data available for Amrutanjan Health Care Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

67
Amrutanjan Health Care Ltd scores 67/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health92/100 · Strong
ROCE 24.8% ExcellentROE 18.5% ExcellentD/E 0.18 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money65/100 · Strong
FII holding stable No changeDII holding up 1.59% MF buyingPromoter holding at 46.5% Stable
Earnings Quality40/100 · Moderate
OPM contracting (16% → 13%) Declining
Quarterly Momentum68/100 · Strong
Revenue (4Q): +10% YoY GrowingProfit (4Q): +12% YoY Positive
Industry Rank60/100 · Moderate
P/E 25.2 vs industry 49.9 Cheaper than peersROCE 24.8% vs industry 24.9% Average3Y sales CAGR: 4% Slow

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily.

Share Price and Basic Stock Data

Last Updated: June 12, 2026, 4:26 am

Market Cap 1,626 Cr.
Current Price 562
Intrinsic Value₹247.62
High / Low 791/486
Stock P/E25.2
Book Value 128
Dividend Yield0.82 %
ROCE24.8 %
ROE18.5 %
Face Value 1.00
PEG Ratio-8.23

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Amrutanjan Health Care Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Amrutanjan Health Care Ltd 1,626 Cr. 562 791/48625.2 1280.82 %24.8 %18.5 % 1.00
Hester Biosciences Ltd 1,667 Cr. 1,960 2,350/1,23931.2 4230.36 %15.2 %15.9 % 10.0
Beta Drugs Ltd 1,496 Cr. 1,476 2,000/99036.1 2410.00 %19.2 %18.8 % 10.0
Jagsonpal Pharmaceuticals Ltd 1,380 Cr. 210 302/15530.9 41.21.19 %22.7 %17.3 % 2.00
Ind-Swift Laboratories Ltd 1,379 Cr. 159 174/87.027.9 1590.00 %4.70 %3.87 % 10.0
Industry Average21,214.12 Cr1,194.5949.88218.190.36%24.92%18.30%6.10

All Competitor Stocks of Amrutanjan Health Care Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 9810078991171278411012313594118141
Expenses 858771929511180969911886101116
Operating Profit 1213772216414231881725
OPM % 12%13%9%7%18%13%4%12%19%13%9%14%18%
Other Income 4544454445443
Interest 0000000000000
Depreciation 1112222222222
Profit before tax 15169924206162621111926
Tax % 26%23%26%26%26%30%27%26%26%27%26%27%26%
Net Profit 1113771714512191581419
EPS in Rs 3.664.342.402.376.044.721.604.086.665.252.874.836.73

Last Updated: February 6, 2026, 6:17 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 18, 2026, 7:16 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 131154174207220253261333406380421452488
Expenses 108130143178192222231258326335369394420
Operating Profit 23253229283131758045525868
OPM % 18%16%18%14%13%12%12%22%20%12%12%13%14%
Other Income 3567878111515161816
Interest 2100000110000
Depreciation 3232334445676
Profit before tax 21263534333534829154626978
Tax % 32%35%35%35%39%29%27%25%26%26%27%26%
Net Profit 15172222202525616740455157
EPS in Rs 4.975.867.687.476.848.398.5820.9322.9913.6315.5517.5819.68
Dividend Payout % 32%30%25%26%22%26%24%20%20%34%30%26%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)13.33%29.41%0.00%-9.09%25.00%0.00%144.00%9.84%-40.30%12.50%13.33%
Change in YoY Net Profit Growth (%)0.00%16.08%-29.41%-9.09%34.09%-25.00%144.00%-134.16%-50.13%52.80%0.83%

Amrutanjan Health Care Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:11%
5 Years:12%
3 Years:4%
TTM:8%
Compounded Profit Growth
10 Years:11%
5 Years:15%
3 Years:-9%
TTM:28%
Stock Price CAGR
10 Years:14%
5 Years:11%
3 Years:-1%
1 Year:-9%
Return on Equity
10 Years:19%
5 Years:20%
3 Years:15%
Last Year:17%

Last Updated: September 4, 2025, 11:10 pm

Balance Sheet

Last Updated: June 16, 2026, 6:00 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 333333333333
Reserves 102118113126143156213262288286324367
Borrowings 002002111222
Other Liabilities 2528343842445784707793137
Total Liabilities 130149152166188205274350362367421509
Fixed Assets 132227282626232849504951
CWIP 4110002171216105
Investments 1410108181818135003
Other Assets 100116115131144161232291307315356349
Total Assets 130149152166188205274350362367421509

Reserves and Borrowings Chart

Cash Flow

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 19218192118915220285136
Cash from Investing Activity + -51-0-8-11-14-88-36-219-31-21
Cash from Financing Activity + -12-11-5-9-7-12-7-17-15-48-13-14
Net Cash Flow 212323-7-4-13-161
Free Cash Flow 132051819168929112115-19
CFO/OP 114%104%77%105%101%95%146%96%81%86%118%73%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow23.0025.0032.0027.0028.0031.0029.0074.0079.0044.0050.0056.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 666255514647371934324245
Inventory Days 454444444045744553585045
Days Payable 44465111010292981061229596113
Cash Conversion Cycle 676148-15-16013-41-35-6-5-23
Working Capital Days 39424576263070289211717399
ROCE %24%26%29%28%25%25%23%44%38%19%21%22%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 50.03%50.03%50.59%50.59%50.59%50.58%46.52%46.52%46.52%46.52%46.52%46.52%
FIIs 0.68%0.69%0.75%0.80%1.38%1.55%2.34%2.30%2.30%2.41%2.38%2.27%
DIIs 7.18%7.22%7.10%7.24%7.29%7.32%10.60%11.13%11.41%12.70%12.90%13.00%
Public 41.93%41.87%41.39%41.19%40.66%40.47%40.50%40.01%39.75%38.34%38.16%38.18%
Others 0.18%0.18%0.18%0.18%0.07%0.07%0.04%0.04%0.04%0.04%0.04%0.04%
No. of Shareholders 69,94771,42872,00268,40462,66457,16954,53653,85651,67449,43147,95446,675

Shareholding Pattern Chart

No. of Shareholders

Amrutanjan Health Care Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
DSP Small Cap Fund 1,466,269 0.53 85.591,466,2692025-04-22 15:57:000%
ICICI Prudential FMCG Fund 715,715 2.35 41.78713,7152026-02-23 08:07:020.28%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 17Mar 16Mar 15Mar 14Mar 13
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 14.4714.0810.318.516.92
Diluted EPS (Rs.) 14.4714.0810.318.516.92
Cash EPS (Rs.) 16.4316.3712.5110.989.47
Book Value[Excl.RevalReserv]/Share (Rs.) 86.2274.4064.9761.0656.29
Book Value[Incl.RevalReserv]/Share (Rs.) 86.2274.4064.9761.0656.29
Revenue From Operations / Share (Rs.) 153.25127.77113.9796.9794.18
PBDIT / Share (Rs.) 23.1624.9519.3216.9314.83
PBIT / Share (Rs.) 21.2022.6617.1314.4712.28
PBT / Share (Rs.) 22.7522.3616.6413.2610.59
Net Profit / Share (Rs.) 14.4714.0810.318.516.92
NP After MI And SOA / Share (Rs.) 14.4714.0810.318.516.92
PBDIT Margin (%) 15.1119.5216.9517.4615.75
PBIT Margin (%) 13.8317.7315.0214.9213.04
PBT Margin (%) 14.8417.5014.6013.6711.24
Net Profit Margin (%) 9.4311.019.048.787.34
NP After MI And SOA Margin (%) 9.4311.019.048.787.34
Return on Networth / Equity (%) 16.7718.9215.8713.9412.29
Return on Capital Employeed (%) 23.8729.4525.5222.7320.83
Return On Assets (%) 13.0714.6512.1610.348.14
Total Debt / Equity (X) 0.010.020.020.080.18
Asset Turnover Ratio (%) 1.481.351.301.121.00
Current Ratio (X) 3.463.593.202.871.67
Quick Ratio (X) 3.153.272.872.551.40
Inventory Turnover Ratio (X) 7.677.096.936.065.44
Dividend Payout Ratio (NP) (%) 0.0027.3433.9337.5843.33
Dividend Payout Ratio (CP) (%) 0.0023.5227.9729.1431.67
Earning Retention Ratio (%) 0.0072.6666.0762.4256.67
Cash Earning Retention Ratio (%) 0.0076.4872.0370.8668.33
Interest Coverage Ratio (X) 78.7283.4739.7214.018.75
Interest Coverage Ratio (Post Tax) (X) 43.9148.1022.208.055.08
Enterprise Value (Cr.) 817.64564.15663.81156.21169.76
EV / Net Operating Revenue (X) 3.653.023.991.101.23
EV / EBITDA (X) 24.1615.4723.516.317.83
MarketCap / Net Operating Revenue (X) 3.853.274.201.291.23
Retention Ratios (%) 0.0072.6566.0662.4156.66
Price / BV (X) 6.855.617.362.062.06
Price / Net Operating Revenue (X) 3.853.274.201.291.23
EarningsYield 0.020.030.020.060.05

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Amrutanjan Health Care Ltd. is a Public Limited Listed company incorporated on 09/09/1936 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24231TN1936PLC000017 and registration number is 000017. Currently Company is involved in the business activities of Manufacture of `ayurvedic' or `unani' pharmaceutical preparation. Company's Total Operating Revenue is Rs. 502.55 Cr. and Equity Capital is Rs. 2.89 Cr. for the Year ended 31/03/2026.
INDUSTRYADDRESSCONTACT
PharmaceuticalsNo.103 (Old No.42-45), Chennai (Madras) Tamil Nadu 600004Contact not found
Management
NamePosition Held
Mr. S Sambhu PrasadChairman & Managing Director
Mr. G RaghavanNon Executive Director
Ms. Ramaa Prabhakar ArikirevulaNon Executive Director
Ms. Meenalochani RaghunathanInd. Non-Executive Director
Mr. Raja VenkataramanInd. Non-Executive Director
Mr. S MuralidharanInd. Non-Executive Director
Mr. V NagarajInd. Non-Executive Director

FAQ

What is the intrinsic value of Amrutanjan Health Care Ltd and is it undervalued?

As of 28 June 2026, Amrutanjan Health Care Ltd's intrinsic value is ₹247.62, which is 55.94% lower than the current market price of ₹562.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (18.5 %), book value (₹128), dividend yield (0.82 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Amrutanjan Health Care Ltd?

Amrutanjan Health Care Ltd is trading at ₹562.00 as of 28 June 2026, with a FY2026-2027 high of ₹791 and low of ₹486. The stock is currently near its 52-week low. Market cap stands at ₹1,626 Cr..

How does Amrutanjan Health Care Ltd's P/E ratio compare to its industry?

Amrutanjan Health Care Ltd has a P/E ratio of 25.2, which is below the industry average of 49.88. This is broadly in line with or below the industry average.

Is Amrutanjan Health Care Ltd financially healthy?

Key indicators for Amrutanjan Health Care Ltd: ROCE of 24.8 % indicates efficient capital utilization; ROE of 18.5 % shows strong shareholder returns. Dividend yield is 0.82 %.

Is Amrutanjan Health Care Ltd profitable and how is the profit trend?

Amrutanjan Health Care Ltd reported a net profit of ₹51 Cr in Mar 2025 on revenue of ₹452 Cr. Compared to ₹67 Cr in Mar 2022, the net profit shows a declining trend.

Does Amrutanjan Health Care Ltd pay dividends?

Amrutanjan Health Care Ltd has a dividend yield of 0.82 % at the current price of ₹562.00. The company pays dividends, though the yield is modest.

Last Updated: June 12, 2026, 4:26 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 590006 | NSE: AMRUTANJAN
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Amrutanjan Health Care Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports